This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Ben Marcune
Introduction
Ben Marcune is a notable inventor based in Bayside, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cyclooxygenase-2 mediated diseases. His work is essential in advancing medical treatments and improving patient outcomes.
Latest Patents
Marcune holds a patent for a process of making cox-2 inhibitors having a lactone bridge. This invention encompasses a process for making compounds of Formula I, which are useful in the treatment of various diseases associated with cyclooxygenase-2. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Ben Marcune is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Marcune has worked alongside esteemed colleagues such as Richard Desmond and Ulf H Dolling. These collaborations have further enhanced his ability to innovate and develop effective pharmaceutical solutions.
Conclusion
Ben Marcune's contributions to the field of pharmaceuticals, particularly through his patent for cox-2 inhibitors, highlight his role as an influential inventor. His work continues to impact the medical community positively.